Who Owns InfuSystem Company?

InfuSystem Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns InfuSystem?

Understanding a company's ownership is key to its strategy and accountability. InfuSystem Holdings, Inc. recently saw a leadership change, with Carrie Lachance becoming CEO on May 19, 2025, succeeding Richard DiIorio.

This transition highlights how leadership shifts can influence a company's direction. InfuSystem, a healthcare service provider, focuses on infusion pumps and related services, particularly for oncology practices.

As of August 2025, InfuSystem Holdings, Inc. has a market capitalization of around $180 million, with 20.4 million shares outstanding. The company's 2024 net revenues reached $134.9 million, a 7.2% increase year-over-year. This growth was seen in both Patient Services and Device Solutions. This analysis will explore InfuSystem's ownership evolution, including institutional and public shareholders, and significant investors. For a deeper dive into the company's market environment, consider the InfuSystem PESTEL Analysis.

InfuSystem Holdings, Inc. began its independent existence in 2005 as a spin-off from I-Flow Corporation. It did not have traditional founders in the startup sense. Instead, its early leadership comprised a management team that transitioned from I-Flow's infusion pump services division. Steven E. Watkins is noted for founding the company in August 2005, which likely refers to the incorporation of HAPC, a blank check company that later acquired InfuSystem from I-Flow Corporation on October 25, 2007.

Independent Public Entity Formation

InfuSystem became an independent public company through a corporate spin-off in 2005. This process separated its operations from its former parent, I-Flow Corporation.

Transitioning Management Team

The initial leadership team for InfuSystem consisted of individuals who were already part of the infusion pump services division at I-Flow. This provided continuity in operational expertise.

Role of Blank Check Company

The company's establishment as a standalone public entity involved a blank check company, HAPC, which acquired InfuSystem in 2007. This is a common method for taking private companies public.

Initial Capitalization

The initial funding and capital structure for InfuSystem were established through the spin-off transaction and the subsequent acquisition by HAPC. This set the stage for its public trading.

Early Ownership Details

Specific details regarding early equity splits or shareholding percentages for the initial management team or investors at the company's inception are not widely publicized.

Distinction from Traditional Startups

The formation through a spin-off and acquisition by a special purpose acquisition company (SPAC) means InfuSystem's early ownership dynamics differed from typical startups that raise capital through angel or venture funding.

The initial capital and funding for InfuSystem Holdings, Inc. were established through its corporate spin-off from I-Flow Corporation in 2005, which also facilitated its transition into a publicly traded entity. While Steven E. Watkins is associated with the company's founding in August 2005, this date likely pertains to the incorporation of HAPC, the blank check company that acquired InfuSystem on October 25, 2007. Publicly available information does not detail specific equity splits or shareholding percentages for the initial management team or early backers at the company's inception as a standalone public entity. The structure of its formation, involving a spin-off and subsequent acquisition by a blank check company, suggests a different early ownership dynamic compared to a conventional startup that might involve angel investors or friends and family funding rounds. Understanding the Marketing Strategy of InfuSystem can provide further context on its early operational focus.

InfuSystem's Genesis and Ownership Structure

InfuSystem Holdings, Inc. was not founded in the traditional sense but emerged as an independent public company in 2005 via a spin-off from I-Flow Corporation. Its subsequent acquisition by a blank check company, HAPC, in 2007 shaped its initial ownership landscape.

• InfuSystem became a public entity in 2005 through a spin-off.
• Steven E. Watkins is linked to the founding date of August 2005, likely for HAPC.
• HAPC acquired InfuSystem on October 25, 2007.
• Early ownership details like equity splits are not publicly disclosed.
• The company's formation differs from typical startup funding models.

InfuSystem SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

InfuSystem Holdings, Inc. transitioned to a publicly traded entity in April 2006, initially under the name HAPC. A significant shift occurred on October 25, 2007, when it acquired InfuSystem from I-Flow Corporation, solidifying its current operational focus. The company's common stock is accessible to investors on the NYSE American exchange, identified by the ticker symbol INFU.

As of the third and fourth quarters of 2024, institutional investors collectively manage a substantial portion, approximately 75%, of InfuSystem's ownership. This broad institutional backing, encompassing mutual funds, pension funds, and investment advisors, is indicative of a well-established public company. The remaining shares are distributed among individual retail investors, with a segment also held by the company's management and board of directors, thereby aligning their interests with the broader shareholder base. While specific details on individual institutional holdings are typically available through SEC filings, the high level of institutional ownership suggests a mature investment profile for InfuSystem. The company's financial standing saw growth, with total assets reaching $143.1 million in fiscal year 2024, an increase from $124.1 million in the preceding year, largely driven by strategic business acquisitions and investments in essential equipment and technology.

Understanding InfuSystem's Shareholder Landscape

The ownership structure of InfuSystem is predominantly held by institutional investors, reflecting its status as a publicly traded company. This broad base of institutional backing is a key indicator of investor confidence and the company's market position.

• Institutional investors own approximately 75% of InfuSystem as of late 2024.
• This includes holdings from mutual funds, pension funds, and investment advisors.
• Retail investors and company insiders hold the remaining shares.
• The company's stock is traded on the NYSE American under the ticker INFU.
• Understanding the Target Market of InfuSystem is crucial for grasping its strategic direction and investor appeal.

InfuSystem PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of mid-2025, InfuSystem Holdings, Inc.'s Board of Directors includes key figures such as Chairman Ronald Hundzinski, appointed in November 2024, and CEO Carrie Lachance, who joined the board in March 2021. The board also features directors Kenneth D. Eichenbaum, M.D., M.S.E., Beverly A. Huss, Dr. John J. Sviokla, Paul A. Gendron, and Scott Shuda, with several recent appointments in 2024 and 2025.

The company operates under a straightforward one-share-one-vote system, meaning each share of common stock grants its holder a single vote on all matters brought before stockholders. As of the March 20, 2025 record date, there were 21,016,415 shares of Common Stock outstanding and eligible to vote. There are no reported dual-class share structures or other mechanisms that would concentrate voting power. While the proportion of independent directors was less than half in December 2024, recent appointments, including the new Chairman, are noted as independent, indicating a move towards enhanced independent oversight. There have been no significant proxy contests or activist campaigns influencing the company’s decision-making processes recently.

Understanding InfuSystem's Corporate Governance

InfuSystem's corporate structure emphasizes a standard voting power distribution. The company's governance is evolving with recent board appointments.

• One-share-one-vote structure
• 21,016,415 shares of Common Stock outstanding as of March 20, 2025
• Recent appointments of independent directors
• No dual-class share structures reported
• Focus on corporate governance and oversight

InfuSystem Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent shifts in leadership and capital allocation strategies highlight evolving trends in InfuSystem's ownership landscape. These changes reflect a proactive approach to enhancing shareholder value and aligning executive interests with those of the company's investors.

InfuSystem's strategic capital management is evident through its recent stock repurchase program. Authorized on May 20, 2024, the company has the flexibility to buy back up to $20 million of its common stock until June 30, 2026. This initiative aims to manage outstanding shares and potentially increase per-share value for existing InfuSystem shareholders. The company also amended its equity plan on May 22, 2025, increasing the share reserve to 6,000,000, a move designed to support talent acquisition and retention, thereby strengthening the overall InfuSystem company structure.

Share Repurchase Program

As of June 30, 2025, InfuSystem had repurchased 596,367 shares for $3.51 million under its current buyback plan. Cumulatively, 1,150,112 shares, representing 5.45% of stock, totaling $7.58 million, have been repurchased since the May 2024 authorization.

Equity Plan Amendment

An amendment on May 22, 2025, increased the equity plan's share reserve to 6,000,000. This is a key step in aligning executive incentives with shareholder interests and attracting top talent.

Leadership Transition

Carrie Lachance assumed the CEO role on May 19, 2025, following Richard DiIorio's departure. Lachance's extensive tenure and board experience position her to guide the company's future direction.

Ownership Trends

These developments reflect a focus on optimizing shareholder returns and strengthening corporate governance. Understanding these shifts is crucial for assessing InfuSystem ownership and its strategic trajectory, as further detailed in the Competitors Landscape of InfuSystem.

InfuSystem Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔